So if ATH434 can slow atrophy in a significant way, then according to what this study shows, ATH434 would slow down th disease progression, making it the first drug to do that.
Forebrain atrophy in early AD, by Masters et al, page-4
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(12.5%) |
Mkt cap ! $18.62M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $7.902K | 2.037M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 53603756 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 126995306 | 20 |
View Market Depth
| Last trade - 14.03pm 15/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |